Skip to main content
SpringerLink
Log in
Book cover

Endocrine Replacement Therapy in Clinical Practice pp 251–272Cite as

Detection and Management of Diabetes Mellitus During Glucocorticoid Therapy of Nonendocrine Disease

  • Chapter

  • 120 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

For the patient who has preexisting type 1 or type 2 diabetes mellitus or the patient with new-onset diabetes during glucocorticoid therapy (steroid diabetes), glucocorticoid therapy of nonendocrine disease poses dilemmas Glucocorticoid therapy exacerbates hyperglycemia, and tapering of a patient’s glucocorticoid dose without adjustment of diabetes therapy may result in severe hypoglycemia. Nevertheless, beneficial glucocorticoid therapy should not be denied to patients having preexisting diabetes or developing steroid diabetes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lim KC, Walsh CH. Diabetic ketoalkalosis: a readily misdiagnosed entity. Br Med J 1976; 2: 19.

    Article  PubMed  CAS  Google Scholar 

  2. Sanders G, Boyle G, Hunter S, Poffenbarger PL. Mixed acid-base abnormalities in diabetes. Diabetes Care 1978; 1: 362–364.

    Article  PubMed  CAS  Google Scholar 

  3. Zinman B The physiologic replacement of insulin: an elusive goal. N Engl J Med 1989;321(6):363–370.

    Google Scholar 

  4. Hawkins JB, Jr, Morales CM, Shipp JC. Insulin requirement in 242 patients with type II diabetes mellitus. Endocrine Prac 1995; 1 (6): 385–389.

    Google Scholar 

  5. Hirsch IB, Paauw DS. Inpatient management of adults with diabetes. Diabetes Care 1995; 18 (6): 870–878.

    PubMed  CAS  Google Scholar 

  6. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parent Enteral Nutr 1998; 22 (2): 77–81.

    Article  CAS  Google Scholar 

  7. Anonymous ADA. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001; 24: S5 - S20.

    Article  Google Scholar 

  8. Anonymous ADA. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001; 24: S33 - S43.

    Article  Google Scholar 

  9. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24 (1): 131–153.

    Article  PubMed  CAS  Google Scholar 

  10. Van den Berghe G, Wouters P, Weekers F, Other ea. Intensive insulin therapy in critically ill patients. New Engl J Med 2001; 19: 1359–1367.

    Article  Google Scholar 

  11. Markovitz L, Wiechmann R, Harris N, et al. Description and evaluation of a glycemic management protocol for diabetic patients undergoing heart surgery. Endocrine Prac 2002; 8 (1): 10–18.

    Google Scholar 

  12. Bookman JJ, Drachman SR, Schaefer LE, Adlersberg D. Steroid diabetes in man. Diabetes 1953; 2 (2): 100–111.

    PubMed  CAS  Google Scholar 

  13. Berg E-G. Nil nocere!: Über Schäden und Nebenwirkungen bei der therapeutischen Verwendung von Cortison und ähnlichen Steroidhormonen. MünchenerMedizinische Wochenschrift 1956; 98: 1614–1622.

    CAS  Google Scholar 

  14. Ranney HM, Gellhorn A. The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Am J Med 1957; 22: 405–413.

    Article  PubMed  CAS  Google Scholar 

  15. Simpson JR. Steroid diabetes-case report. Harper Hospital Bull 1957; 15: 43–51.

    CAS  Google Scholar 

  16. Grilliat J-P, Koenig E, Vaillant G. Diabéte survenant au cours de cirrhoses traitées par delat-cortisone. Revue Médicale de Nancy 1959; 84: 720–727.

    PubMed  CAS  Google Scholar 

  17. Baldwin HS, Dworetzky M, Isaacs NJ. Evaluation of the steroid treatment of asthma since 1950. J Allergy 1961; 32: 109–118.

    Article  PubMed  CAS  Google Scholar 

  18. Gregory RL, Sayle BA. Steroid diabetes. TX St J Med 1962; 58: 788–793.

    CAS  Google Scholar 

  19. Blereau RP, Weingartern CM. Diabetic acidosis secondary to steroid therapy. N Engl J Med 1964; 271: 836.

    Article  PubMed  CAS  Google Scholar 

  20. Mach RS, de Sousa RC. Coma avec hyperosmolalité et déshydratation chez des malades hyperglycémiques sans acidocétose. Schweizerishce Medizinische Wochenschrift 1963; 36: 1256–1263.

    Google Scholar 

  21. Keeney EL. The condition of asthmatic patients after daily long-term corticosteroid treatment. AZ Med 1964; 21: 463–469.

    CAS  Google Scholar 

  22. Miller SEP, Neilson Jm. Clinical features of the diabetic syndrome appearing after steroid therapy. Postgrad Medical J 1964; 40: 660–669.

    Article  CAS  Google Scholar 

  23. Brocard H, Akoun G, Grand A. Diabète stéroïde compliqué d’un coma de type hyperosmolaire. Bulletins et Mémoires de la Société Médicale des Hôpitaux de Paris 1965; 116: 353–363.

    PubMed  CAS  Google Scholar 

  24. Schwartz TB, Apfelbaum RI. Nonketotic diabetic coma. In: Schwartz TB, ed. Year Book of Endocrinology (1965–1966 Year Book Series). Year Book Publishers, Chicago, IL, 1965–1966, pp. 165–181.

    Google Scholar 

  25. Coles RS. Steroid therapy in uveitis. International Ophthalmology Clinics 1966; 6 (4): 869–901.

    Article  PubMed  CAS  Google Scholar 

  26. Walsh SD, Grant IWB. Corticosteroids in treatment of chronic asthma. Br Med J 1966; 2: 796–802.

    Article  PubMed  CAS  Google Scholar 

  27. Boyer MH. Hyperosmolar anacidotic coma in association with glucocorticoid therapy. JAMA 1967; 202: 95–1009.

    Article  Google Scholar 

  28. Plauchu M, Paliard P, Malluret J, Noel P, de Montgolfier R. Un nouveau cas d’ état d’ hyperosmolarité plasmatique ou de coma hyperosmolaire déclenché par les corticoïdes chez un diabétique latent, porteur d’une lymphose. Lyons Med 1967; 217 (26): 1921–1932.

    CAS  Google Scholar 

  29. Zangel V, Masszi J. Ketozisba atmenö steroid-diabetes harom esete. Orvosi Hetilap 1967; 108: 395, 396.

    Google Scholar 

  30. Kumar RS. Hyperosmolar non-ketotic coma. Lancet 1968; 1: 48, 49.

    Google Scholar 

  31. Pyörälä K, Suhonen O, Pentikäinen P. Steroid therapy and hyperosmolar non-ketotic coma. Lancet 1968; 1: 596–597.

    Article  PubMed  Google Scholar 

  32. Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 1968; 23: 571–581.

    Article  PubMed  CAS  Google Scholar 

  33. Williams ER. Systemic lupus erythematosus and diabetes mellitus. Br J Clin Prac 1968; 22: 461–463.

    CAS  Google Scholar 

  34. Spenney JG, Eure CA, Kreisberg RA. Hyperglycemic, hyperosmolar, nonketoacidotic diabetes: a complication of steroid and immunosuppressive therapy. Diabetes 1969; 18: 107–110.

    PubMed  CAS  Google Scholar 

  35. Alavi IA, Sharma BK, Pillay VKG. Steroid-induced diabetic ketoacidosis. Am J Med Sci 1971; 262 (1): 1971.

    Article  Google Scholar 

  36. Limas CJ, Samad A, Seff D. Hyperglycemic nonketotic coma as complication of steroid therapy. NY St J Med 1971; 71: 1542, 1543.

    Google Scholar 

  37. Corcoran FH, Granatir RF, Schlang HA. Hyperglycemic hyperosmolar nonketotic coma associated with corticosteroid therapy. J FL Med Assoc 1971; 58: 38–39.

    CAS  Google Scholar 

  38. Lieberman P, Patterson R, Kunske R. Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol 1972; 49: 329–336.

    Article  PubMed  CAS  Google Scholar 

  39. Klein W. Behandlung mit Glukokortikoiden bei Diabetikern. Zeitschrigft für Allgemeinmedizin 1974; 25: 1101–1105.

    Google Scholar 

  40. Koehler BE, Urowitz MB, Killinger DW. The systemic effects of intra-articular corticosteroid. J Rheumatol 1974; 1: 117–125.

    PubMed  CAS  Google Scholar 

  41. David DS, Cheigh JS, Braun DW, Fotino M, Stenzel KH, Rubin AL. HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA 1980;243(6):532,533.

    Google Scholar 

  42. Gottlieb NL, Riskin WG. Complications of local corticosteroid injections. JAMA 1980; 243: 1547, 1548.

    Google Scholar 

  43. Armstrong RD, English J, Gibson T, Chakroborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981; 40: 571–574.

    Article  PubMed  CAS  Google Scholar 

  44. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 1983; 72: 1814–1820.

    Article  PubMed  CAS  Google Scholar 

  45. Fujikawa LS, Meisler DM, Nozik RA. Hyperosmolar hyperglycemic nonketotic coma. Ophthalmology 1983; 90: 1239–1242.

    PubMed  CAS  Google Scholar 

  46. Ivanova II, Vasiutkova LA, Ivanov VA. Hyperglycemic coma after corticosteroid therapy. Sovetskaia Meditsina 1984; 10: 112, 113.

    Google Scholar 

  47. Lohr KM. Precipitation of hyperosmolar nonketotic diabetes on alternate-day corticosteroid therapy. JAMA 1984; 252 (5): 628.

    Article  PubMed  CAS  Google Scholar 

  48. Ferguson RP. A comparison of steroid and thiazide diabetes. CT Med 1986; 50: 506–509.

    CAS  Google Scholar 

  49. Bruno A, Cavallo-Perin P, Cassader M, Pagano G. Deflazacort vs prednisone: effect on blood glucose control in insulin-treated diabetes. Arch intern Med 1987; 147: 679, 680.

    Google Scholar 

  50. Greenstone MA, Shaw AB. Alternate day corticosteroid causes alternate day hyperglycemia. Postgrad Med J 1987; 63 (743): 761–764.

    Article  PubMed  CAS  Google Scholar 

  51. Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med 1987; 147: 499–501.

    Article  PubMed  CAS  Google Scholar 

  52. Thomas JW, Vertkin A, Nell LJ. Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes. J Rheumatol 1987; 14 (4): 732–735.

    PubMed  CAS  Google Scholar 

  53. Black DM, Filak AT. Hyperglycemia with non-insulin dependent diabetes following intraarticular steroid injection. J Fam Prac 1989;28(4):462,463.

    Google Scholar 

  54. Pagano G, Bruno A, Cavallo-Perin P, Cesco L. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Arch Intern Med 1989; 149: 1093–1101.

    Article  Google Scholar 

  55. Shi M-z, Zhang S-f. Steroid diabetes: an analysis of 28 cases. Chin J Int Med 1989;28(3):139–141;185.

    Google Scholar 

  56. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 1994; 154: 97–101.

    Article  PubMed  CAS  Google Scholar 

  57. Siminerio LM, Carroll PB. Educating secondary diabetes patients. Diabetes Spectrum 1994; 7 (1): 8–14.

    Google Scholar 

  58. Haggerty RD, Bergsman K, Edelson GW. Steroid-induced diabetic ketoacidosis. Prac Diabetol 1995; 14 (2): 24–25.

    Google Scholar 

  59. Braithwaite SS, Barr WG, Thomas JD. Diabetes management during glucocorticoid therapy of nonendocrine disease. Endocrine Prac 1996; 2: 320–325.

    CAS  Google Scholar 

  60. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin N Am 1997; 26 (3): 631–645.

    Article  CAS  Google Scholar 

  61. Braithwaite SS, Barr WG, Rahman A, Quddusi S. Managing diabetes during glucocorticoid therapy. Postgrad Med 1998;104(5):163–166,171,175,176.

    Google Scholar 

  62. Okumura S, Takeda N, Takami K, et al. Effects of troglitazone on dexamethasone-induced insulin resistance in rats. Metabolism 1998; 47 (3): 351–354.

    Article  PubMed  CAS  Google Scholar 

  63. Tanaka M, Endo K, Suzuki T, Maruyama Y, Kondo A. Treatment for steroid-induced diabetes with alpha-glucosidase inhibitor, voglibose. Eur J Neurol 1998; 5 (3): 315.

    Article  PubMed  Google Scholar 

  64. Braithwaite SS, Barr WG, Rahman A, Quddusi S. An algorithm for diabetes management during glucocorticoid therapy of nonendocrine disease. In: Meikle AW, ed. Hormone Replacement Therapy. 1st ed. Humana Press, Totowa, NJ, 1999, pp. 191–207.

    Google Scholar 

  65. Carolan J. Insulin versus oral agents for `steroid-induced’ diabetes [letter; comment]. Postgrad Med 1999; 105 (5): 36.

    PubMed  CAS  Google Scholar 

  66. Hoogwerf B, Danese RD. Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin N Am 1999; 25 (3): 489–505.

    Article  CAS  Google Scholar 

  67. Fujibayashi K, Nagasaka S, Itabashi N, et al. Troglitazone efficacy in a subject with glucocorticoidinduced diabetes. Diabetes Care 1999;22(12): 2088, 2089.

    Google Scholar 

  68. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340: 1941–1947.

    Article  PubMed  CAS  Google Scholar 

  69. Pauw DS. Case study: a 60-year-old woman with type 2 diabetes and COPD: worsening hyperglycemia due to prednisone. Clin Diabetes 2000;18(2):89,90.

    Google Scholar 

  70. Morita H, Oki Y, Ito T, Ohishi H, Suzuki S, Nakamura H. Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM. Diabetes Care 2001;24(4):788,789.

    Article  Google Scholar 

  71. Volgi J, Baldwin DJ. Glucocorticoid therapy and diabetes management. Nurs Clin N Am 2001; 36 (2): 333–339.

    CAS  Google Scholar 

  72. Long CNH, Katzin B, Fry EG. The adrenal cortex and carbohydrate metabolism. Endocrinology 1940; 26: 309–344.

    Article  CAS  Google Scholar 

  73. Ingle DJ, Sheppard R, Evans JS, Kuizenga MH. A comparison of adrenal steroid diabetes and pancreatic diabetes in the rat. Endocrinology 1945; 37: 341–356.

    Article  PubMed  CAS  Google Scholar 

  74. Owen 0E, Cahill GF. Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest 1973; 52: 2596–2605.

    Article  PubMed  CAS  Google Scholar 

  75. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man• impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 1982; 54: 131–138.

    Article  PubMed  CAS  Google Scholar 

  76. Weinstein ST, Holand A, O’Boyle E, Haber RS. Effects of thiazolidinediones on glucocorticoidinduced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 1993; 42 (10): 1365–1369.

    Article  PubMed  CAS  Google Scholar 

  77. Tappy L, Randin D, Vollenweider P, et al. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab. 1994; 79 (4): 1063–1069.

    Article  PubMed  CAS  Google Scholar 

  78. Matsumoto K, Yamasalci H, Akazawa S, et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 1996; 81 (7): 2621–2626.

    Article  PubMed  CAS  Google Scholar 

  79. Henriksen JE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 1997; 40: 1439–1448.

    Article  PubMed  CAS  Google Scholar 

  80. Daouk AA, Malek GH, Kauffman HM, Kisken WA. Hyperosmolar non-ketotic coma in a kidney transplant recipient. J Urol 1972; 108: 524, 525.

    Google Scholar 

  81. Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Buselmeier TJ, Najarian JS. Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery 1973; 73 (5): 759–765.

    PubMed  CAS  Google Scholar 

  82. Hill CM, Douglas JF, Rajkumar KV, McEvoy J, McGeown MG. Glycosuria and hyperglycaemia after kidney transplantation. Lancet 1974; 2: 490–542.

    Article  PubMed  CAS  Google Scholar 

  83. Woods JE, Zincke H, Palumbo PJ, et al. Hyperosmolar nonketotic syndrome and steroid diabetes. JAMA 1975; 231: 1261–1263.

    Article  PubMed  CAS  Google Scholar 

  84. Gunnarsson R, Amer P, Lundgren G, Magnusson G, Östman J, Groth CG. Steroid diabetes after renal transplantation-a preliminary report. Scand J Urol Nephrol 1977; 42: 191–194.

    Google Scholar 

  85. Gunnarsson R, Lundgren G, Magnusson G, Ost L, Groth CG. Steroid diabetes-a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol 1980; 54: 135–138.

    CAS  Google Scholar 

  86. Pagano G, Lombardi A, Ferraris GM, Imbimbo B, Perin PC. Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects. Eur J Clin Pharmacol 1982; 22: 469–471.

    Article  PubMed  CAS  Google Scholar 

  87. Amer P, Gunnarsson R, Blomdahl S, Carl-Gustav G. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 1983; 6 (1): 23–25.

    Article  Google Scholar 

  88. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989; 47 (2): 278–281.

    Article  PubMed  CAS  Google Scholar 

  89. Ekstrand AV. Effect of steroid-therapy on insulin sensitivity in insulin-dependent diabetic patients after kidney transplantation. J Diabetic Complic 1991; 5 (4): 244–248.

    Article  CAS  Google Scholar 

  90. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporin-treated renal transplant recipients. Transplantation 1991; 51 (2): 374–377.

    Article  PubMed  CAS  Google Scholar 

  91. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporin era-an analysis of risk factors. Transplantation 1991; 51 (2): 343–347.

    Article  PubMed  CAS  Google Scholar 

  92. Sumrani NB, Delaney V, Daskalakis P, et al. Retrospective analysis of posttransplantation diabetes mellitus in black renal allograft recipients. Diabetes Care 1991; 14 (8): 760–762.

    Article  PubMed  CAS  Google Scholar 

  93. Vesco L, Busson M, Lang P. Characteristics of postrenal transplant diabetes mellitus. Transplant Proc 1995;27(4): 2465, 2466.

    Google Scholar 

  94. Ekstrand A, Schalin-Jäntti C, Löfman M, et al. The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation. Transplantation 1996; 61 (6): 889–893.

    Article  PubMed  CAS  Google Scholar 

  95. Vesco L, Busson M, Bedrossian J, Bitker M, Hiesse C, Lang P. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996; 61 (10): 1475–1478.

    Article  PubMed  CAS  Google Scholar 

  96. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64 (7): 979–983.

    Article  PubMed  CAS  Google Scholar 

  97. Kirkman MS, Wittle B, Benzing M, Johnson P. Hyperosmolar non-ketotic state as first manifestation of diabetes mellitus. Diabetes Spec 1997;10(3):175,176.

    Google Scholar 

  98. Veenstra DL. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999; 33 (5): 829–839.

    Article  PubMed  CAS  Google Scholar 

  99. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999; 34 (1): 1–13.

    Article  PubMed  CAS  Google Scholar 

  100. Depczynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. 2000; 17 (1): 15–19.

    CAS  Google Scholar 

  101. Jindahl RM. Impact and management of posttransplant diabetes mellitus. Transplantation 2000;70:ss58–63.

    Google Scholar 

  102. Tenderich G, Schulte-Eistrup S, Petzoldt R, Koerfer R. Cardiac transplantation in patients with insulin-treated diabetes mellitus. 2000.

    Google Scholar 

  103. Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transplantation 2001; 7 (3): 234–237.

    Article  Google Scholar 

  104. Duijnhoven EM, Boots JM, Christiaans MH, Wolffenbuttel BH, Van Hooff JP. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol 2001; 12 (3): 583–588.

    PubMed  CAS  Google Scholar 

  105. Hjelmesaeth J, Hartmann A, Midtvedt K, et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol, Dial Transplant 2001; 16 (5): 1047–1052.

    Article  CAS  Google Scholar 

  106. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol, Dial Transplant 2001; 16 (4): 829–835.

    Article  CAS  Google Scholar 

  107. Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71 (10): 1417–1423.

    Article  PubMed  CAS  Google Scholar 

  108. Nieuwenhuis MG, Kirkels JH. Predictability and other aspects of post-transplant diabetes mellitus in heart transplant recipients. J Heart Lung Transplant 2001; 20 (7): 703–708.

    Article  PubMed  CAS  Google Scholar 

  109. Paolillo JA, Boyle GJ, Law YM, et al. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. Transplantation 2001; 71 (2): 252–256.

    Article  PubMed  CAS  Google Scholar 

  110. Steinmuller T, Stockmann M, Jonas S, et al. The impact of liver transplantation on diabetes mellitus. Transplant Proc 2001; 33 (1–2): 1393.

    Article  PubMed  CAS  Google Scholar 

  111. Sutherland DER, Gruessner RWG, Dunn DL, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001; 233 (4): 463–501.

    Article  PubMed  CAS  Google Scholar 

  112. Szewczyk Z, Ratajczyk T, Rabczynski J. Hyperosmotic coma in steroid-induced diabetes complicating subacute glomerulonephritis in a 16-year-old boy. Polski Tygodnik Lekarski 1971; 26: 1988–1990.

    PubMed  CAS  Google Scholar 

  113. Perlman K, Ehrlich RM. Steroid diabetes in childhood. Am J Dis Child 1982; 136: 64–68.

    PubMed  CAS  Google Scholar 

  114. Robert JJ, Tete MJ, Crosnier H, Broyer M. Diabète sucré aprés transplantation rénale chez l’ enfant. Ann Pédiatr (Paris) 1993; 40 (2): 112–118.

    CAS  Google Scholar 

  115. Covar RA, Leung DYM, Mc Cormick D, Steelman J, Zeitler P, Spahn JD. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 2000; 106 (4): 651–659.

    Article  PubMed  CAS  Google Scholar 

  116. Bouhanick B, Biquard F, Hadjadj S, Roques MA. Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)? Arch Intern Med 2000; 160: 242, 243.

    Google Scholar 

  117. Wiczynska-Zajac A, Bomba-Opon DA, Domanska-Janczewska E, Jozwicka E, Marianowski L. The influence of prenatal glucocorticoids on glycemic control among pregnant women with type I diabetes. Ginekologia Polska 2000; 71 (8): 900–905.

    PubMed  CAS  Google Scholar 

  118. Pearson DW, Thomson JA, Kennedy AC, Toner PG, Ratcliffe JG. Diabetic ketoalkalosis due to ectopic ACTH production from an oat cell carcinoma. Postgrad Med J 1981; 57: 455, 456.

    Google Scholar 

  119. Kendall-Taylor P. Hyperosmolar coma in Cushing’s disease. Lancet 1974; 1: 409.

    Article  Google Scholar 

  120. Kreze A, Mikulecky M, Moravick M. Factors influencing the development of glucose intolerance in Cushing syndrome. Acta Medica Austriaca 1995; 22 (5): 110–112.

    PubMed  CAS  Google Scholar 

  121. Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing’ s syndrome: an unexpected frequent cause or poor glycemic control in obsese diabetic patients. Clin Endocrinol 1996; 44: 717–722.

    Article  CAS  Google Scholar 

  122. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol. Arch Intern Med 1997; 157: 1651–1656.

    Article  PubMed  CAS  Google Scholar 

  123. Arai J, Miyakawa Y, Kataoka K, Matsuki S, Asano S. Case of fatal hypoglycemic coma during sulfonylurea administration for the therapy of steroid diabetes following adrenalectomy. Saishin Igaku Recent Med 1969; 1969 (24): 2524–2529.

    Google Scholar 

  124. McConnell EM, Bell PM, Hadden DR, McCance DR, Sheridan B, Atkinson AB. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy. Clin Endocrinol 200l;54(5):593–599.

    Article  Google Scholar 

Download references

Authors
  1. Susan S. Braithwaite MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Pathology, University of Utah School of Medicine and ARUP Laboratory, Salt Lake City, UT, USA

    A. Wayne Meikle MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Braithwaite, S.S. (2003). Detection and Management of Diabetes Mellitus During Glucocorticoid Therapy of Nonendocrine Disease. In: Meikle, A.W. (eds) Endocrine Replacement Therapy in Clinical Practice. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-375-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-375-0_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-416-6

  • Online ISBN: 978-1-59259-375-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation